DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia JA Timms, CL Relton, J Rankin, G Strathdee, JA McKay Epigenomics 8 (4), 519-536, 2016 | 37 | 2016 |
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes N van Leeuwen-Kerkhoff, TM Westers, PJ Poddighe, GAM Povoleri, ... Haematologica 107 (3), 655, 2022 | 18 | 2022 |
Exploring a potential mechanistic role of DNA methylation in the relationship between in utero and post‐natal environmental exposures and risk of childhood acute … JA Timms, CL Relton, GC Sharp, J Rankin, G Strathdee, JA McKay International journal of cancer 145 (11), 2933-2943, 2019 | 17 | 2019 |
ImmunoCluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data JW Opzoomer, JA Timms, K Blighe, TP Mourikis, N Chapuis, R Bekoe, ... Elife 10, e62915, 2021 | 11 | 2021 |
DNA methylation and the hygiene hypothesis: connecting respiratory allergy and childhood acute lymphoblastic leukemia SAS Langie, JA Timms, P De Boever, JA McKay Epigenomics 11 (13), 1519-1537, 2019 | 5 | 2019 |
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect F Guardalupi, C Sorrentino, G Corradi, R Giancola, S Baldoni, F Ulbar, ... Leukemia 37 (7), 1572-1575, 2023 | 4 | 2023 |
ImmunoCluster: A computational framework for the non-specialist to immune profile cellular heterogeneity using liquid and imaging mass, and flow cytometry datasets JW Opzoomer, J Timms, K Blighe, TP Mourikis, N Chapuis, R Bekoe, ... bioRxiv, 2020.09. 09.289033, 2020 | 3 | 2020 |
Immunocluster: a computational tool to explore the immune profile and cellular heterogeneity of hematological diseases using liquid and imaging mass, and flow cytometry data JA Timms, JW Opzoomer, K Blighe, B Apollonio, T Mourikis, N Chapuis, ... Blood 136, 9-10, 2020 | 2 | 2020 |
Attenuated Immune Responses to the Annual Influenza A Vaccine in Patients with Myeloproliferative Neoplasms S Alimam, JA Timms, R Dillon, T Mare, D Radia, H De Lavallade, ... Blood 134, 1673, 2019 | 2 | 2019 |
Novel Simultaneous Single Cell mRNA and Protein Expression Profiling Identifies Distinct Treg and T Effector Signatures in the Bone Marrow of MDS Patients JA Timms, S Winter, S Hargreaves, DP McLornan, U Platzbecker, ... Blood 134, 2980, 2019 | 1 | 2019 |
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms S Winter, M Schneider, U Oelschlaegel, G Maggioni, E Riva, MG Raddi, ... Leukemia, 1-5, 2024 | | 2024 |
42P Independent prognostic value of flow cytometry (FCM) in myelodysplastic syndromes (MDS): Composition of a prognostic FCM-score for overall survival A Santaolalla, U Oelschlaegel, J Timms, S Winter, P Parker, CN Harrison, ... Annals of Oncology 33, S1396, 2022 | | 2022 |
APPLICATION OF AI-BASED ANALYTICAL APPROACHES FOR MULTIPLEX IMMUNOPHENOTYPING OF SF3B1-MUTANT MYELODYSPLASTIC SYNDROME SUBTYPE S Winter, J Timms, U Oelschlaegel, A Tunger, P Parker, C Harrison, ... HAEMATOLOGICA 107, 15-16, 2022 | | 2022 |
Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS)-Composition of a Prognostic FCM-Score for Overall Survival U Oelschlaegel, A Santaolalla, JA Timms, S Winter, K Sockel, ... Blood 138, 2603, 2021 | | 2021 |
Application of AI-Based Analytical Approaches for Multiplex Immunophenotyping of SF3B1-Mutant Myelodysplastic Syndrome Subtype S Winter, JA Timms, U Oelschlaegel, A Tunger, CN Harrison, D Choy, ... Blood 138, 1512, 2021 | | 2021 |
DNA Methylation as a Potential Mediator of Early Life Exposures on Risk of Childhood Acute Lymphoblastic Leukaemia (ALL) JA Timms Newcastle University, 2017 | | 2017 |
REDUCED FREQUENCIES AND FUNCTIONAL IMPAIRMENT OF DENDRITIC CELL SUBSETS AND NON-CLASSICAL MONOCYTES IN MDS N van Leeuwen-Kerkhoff, TM Westers, PJ Poddighe, GAM Povoleri, ... DENDRITIC CELLS, 93, 0 | | |